A detailed history of Portman Square Capital LLP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Portman Square Capital LLP holds 8,513 shares of ALNY stock, worth $2.32 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
8,513
Previous 11,848 28.15%
Holding current value
$2.32 Million
Previous $2.88 Million 18.69%
% of portfolio
0.09%
Previous 0.11%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$233.81 - $287.01 $779,756 - $957,178
-3,335 Reduced 28.15%
8,513 $2.34 Million
Q2 2024

Jul 19, 2024

SELL
$143.31 - $247.0 $598,319 - $1.03 Million
-4,175 Reduced 26.06%
11,848 $2.88 Million
Q1 2024

Apr 15, 2024

BUY
$146.51 - $198.2 $1.47 Million - $1.99 Million
10,060 Added 168.71%
16,023 $2.39 Million
Q4 2023

Jan 19, 2024

SELL
$151.41 - $196.57 $901,040 - $1.17 Million
-5,951 Reduced 49.95%
5,963 $1.14 Million
Q3 2023

Oct 30, 2023

BUY
$170.77 - $211.65 $366,472 - $454,200
2,146 Added 21.97%
11,914 $2.11 Million
Q2 2023

Jul 26, 2023

BUY
$185.01 - $212.05 $902,108 - $1.03 Million
4,876 Added 99.67%
9,768 $1.86 Million
Q1 2023

May 04, 2023

BUY
$182.66 - $235.53 $893,572 - $1.15 Million
4,892 New
4,892 $979,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $33.5B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Portman Square Capital LLP Portfolio

Follow Portman Square Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portman Square Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Portman Square Capital LLP with notifications on news.